Outlook on the Global Parathyroid Hormone Market Forecast Period 2022-2031

Outlook on the Global Parathyroid Hormone Market Forecast Period 2022-2031
Global Parathyroid Hormone Market Report 2022: Market Size, Trends and Global Forecast 2022-2026

Global Parathyroid Hormone Market Report 2022: Market Size, Trends and Global Forecast 2022-2026

The Business Research Company Global Parathyroid Hormone Market Report 2022: Market Size, Trends and Global Forecast 2022-2026

LONDON, GREATER LONDON, UK, October 24, 2022 /EINPresswire.com/ — Reports have been updated with the most recent impact of the Ukraine-Russia War on market growth for all 27+ industries. The reports also provide possible solutions and opportunities to survive this crisis.

According to “Global Parathyroid Hormone Market Report 2022” by The Business Research Company, the parathyroid hormone market is expected to reach $2.51 billion in 2026 with a CAGR of 4%. The increase in the prevalence of osteoporosis is expected to drive the growth of the parathyroid hormone market.

Request a sample now to better understand the parathyroid hormone market:

Key trends in the parathyroid hormone market
According to parathyroid hormone market research, companies are focusing on developing a biosimilar of parathyroid-based drugs. A biosimilar is a biological product that is developed to be similar to a biologic already approved by the FDA, known as a reference product. Biosimilars potentially offer consumers the opportunity to lower their health care costs without compromising treatment standards, which is why companies that make parathyroid hormone are investing in it. For example, in August 2019, Gedeon Richter announced the launch of a biosimilar teriparatide called Terrosa.® in Europe. In August 2020, Cadila Pharmaceuticals launched a biosimilar of teriparatide (NuPTH) intended for osteoporosis.

Parathyroid Hormone Market Overview
The parathyroid hormone market consists of sales of parathyroid hormones and related services by entities (organizations, sole traders, and associations) that develop parathyroid hormones to treat various diseases. Parathyroid hormone is responsible for regulating the distribution of phosphate and calcium in the body and is used in the treatment of diseases such as hypothyroidism and osteoporosis.

Learn more about the Parathyroid Hormone Global Market Report at:

TBRC Global Parathyroid Hormone Market Report 2022 covers the following information:
Market size data
• Forecast Period: Historical and Future
• By region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, US, South America, Middle East, and Africa.
• By countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, United Kingdom, United States.

Market segmentation
• By type of disease: hypocalcaemia, hypoparathyroidism
• By end user: hospitals, clinics, others
• By type of product: recombinant parathyroid hormone, parathyroid hormone analogs
• By geography: The global parathyroid hormone market report is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East, and Africa. Among these regions, North America has the largest market share.

Major market players such as Pfizer Inc, Eli Lilly and Company, Radius Health Inc, Shire, Ascendis Pharma, Entera Bio Ltd., Extend Biosciences Inc., and Gedeon Richter Plc.

Trends, opportunities, strategies and much more.

The Global Parathyroid Hormone Market Report 2022 is one of the comprehensive reports by The Business Research Company that provides an overview of the global parathyroid hormone market. The market report analyzes the global parathyroid hormone market size, global parathyroid hormone market growth drivers, global parathyroid hormone market segments, major parathyroid hormone market players, global parathyroid hormone market growth parathyroid hormone across all geographies and revenue and market positioning of competitors in the global parathyroid hormone market. The Global Parathyroid Hormone Market report enables you to gain insights into opportunities and strategies, as well as identify countries and segments with the highest growth potential.

Not what you were looking for? Read similar reports from The Business Research Company:

Global Antithyroid Drugs Market Report 2022

Global Drugs for Metabolic Disorders Market Report 2022

Global Biosimilar Growth Hormones Market Report 2022

About the business research company

Business Research Company has published more than 3,000 industry reports, covering more than 3,000 market segments and 60 geographies. The reports are based on 150,000 data sets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with detailed analysis of the impact of COVID-19 on various markets.

Take a look at our:
business research company
Europe: +44 207 1930 708
Asia: +91 8897263534
America: +1 315 623 0293
Email: info@tbrc.info

Take a look at our:
TBRC blog: http://blog.tbrc.info/
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
Youtube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
World market model: https://www.thebusinessresearchcompany.com/global-market-model
Health Blog: https://healthcareresearchreports.com/

Oliver Guirdham
business research company
+44 20 7193 0708
Visit us on social networks:

Market research products, services and solutions for your business – TBRC

Leave a Comment